NPPB and hydrops fetalis: Additionally, a secondary analysis of the REDEAL HF trial found that elevated baseline NT-proBNP levels (> 1,153 pg/mL) was the strongest independent risk factor of future cardiovascular events among patients with HFrEF both with or without improved LVEF [34].